Race Oncology Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Race Oncology.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Biotechs earnings growth | 16.2% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
No updates
Recent updates
We're Not Very Worried About Race Oncology's (ASX:RAC) Cash Burn Rate
Jan 23Here's Why We're Not Too Worried About Race Oncology's (ASX:RAC) Cash Burn Situation
Oct 05Companies Like Race Oncology (ASX:RAC) Are In A Position To Invest In Growth
Jun 20We're Interested To See How Race Oncology (ASX:RAC) Uses Its Cash Hoard To Grow
Feb 17Here's Why We're Not At All Concerned With Race Oncology's (ASX:RAC) Cash Burn Situation
Oct 14Here's Why We're Not Too Worried About Race Oncology's (ASX:RAC) Cash Burn Situation
Apr 01We're Hopeful That Race Oncology (ASX:RAC) Will Use Its Cash Wisely
Apr 05What Percentage Of Race Oncology Limited (ASX:RAC) Shares Do Insiders Own?
Mar 01How Much Are Race Oncology Limited (ASX:RAC) Insiders Taking Off The Table?
Jan 07In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Race Oncology has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2023 | 6 | -11 | -13 | -13 | N/A |
9/30/2023 | 4 | -11 | -12 | -12 | N/A |
6/30/2023 | 3 | -10 | -11 | -11 | N/A |
3/31/2023 | 2 | -10 | -10 | -10 | N/A |
12/31/2022 | 1 | -11 | -9 | -9 | N/A |
9/30/2022 | 1 | -11 | -8 | -8 | N/A |
6/30/2022 | 1 | -11 | -6 | -6 | N/A |
3/31/2022 | 1 | -10 | -6 | -6 | N/A |
12/31/2021 | 1 | -9 | -6 | -6 | N/A |
9/30/2021 | 1 | -8 | -5 | -5 | N/A |
6/30/2021 | 0 | -6 | -5 | -5 | N/A |
3/31/2021 | 0 | -5 | -4 | -4 | N/A |
12/31/2020 | 0 | -4 | -3 | -3 | N/A |
9/30/2020 | 0 | -4 | -3 | -3 | N/A |
6/30/2020 | 0 | -4 | -2 | -2 | N/A |
3/31/2020 | 0 | -3 | -2 | -2 | N/A |
12/31/2019 | 0 | -3 | -2 | -2 | N/A |
9/30/2019 | 0 | -3 | -2 | -2 | N/A |
6/30/2019 | 0 | -4 | -3 | -3 | N/A |
3/31/2019 | 0 | -4 | -3 | -3 | N/A |
12/31/2018 | 0 | -5 | -3 | -3 | N/A |
9/30/2018 | 0 | -6 | -3 | -3 | N/A |
6/30/2018 | 0 | -6 | -4 | -4 | N/A |
3/31/2018 | 0 | -6 | -4 | -4 | N/A |
12/31/2017 | 0 | -6 | -4 | -4 | N/A |
9/30/2017 | 0 | -5 | N/A | -3 | N/A |
6/30/2017 | N/A | -4 | N/A | -2 | N/A |
3/31/2017 | N/A | -3 | N/A | -2 | N/A |
12/31/2016 | N/A | -2 | N/A | -1 | N/A |
9/30/2016 | N/A | -1 | N/A | -1 | N/A |
6/30/2016 | N/A | 0 | N/A | 0 | N/A |
3/31/2016 | N/A | 0 | N/A | 0 | N/A |
12/31/2015 | N/A | 0 | N/A | 0 | N/A |
9/30/2015 | N/A | 0 | N/A | 0 | N/A |
6/30/2015 | N/A | 0 | N/A | 0 | N/A |
6/30/2014 | N/A | 0 | N/A | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if RAC's forecast earnings growth is above the savings rate (2.2%).
Earnings vs Market: Insufficient data to determine if RAC's earnings are forecast to grow faster than the Australian market
High Growth Earnings: Insufficient data to determine if RAC's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if RAC's revenue is forecast to grow faster than the Australian market.
High Growth Revenue: Insufficient data to determine if RAC's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if RAC's Return on Equity is forecast to be high in 3 years time